[1]
2026. Risk Assessment of QT-Prolonging Drug Combinations and Their Association with QTc Interval Prolongation Among Psychiatric Patients: A Prospective Observational Study. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/rveyrh87.